Navigation Links
Transitioning from Bench into Clinical Phase, new webinar hosted by Xtalks
Date:8/26/2014

Toronto, Canada (PRWEB) August 26, 2014

Historically, drug development has faced a number of challenges and the list continues to grow – high attrition rate, low productivity, patent expiry, rising costs of research and development, high regulatory hurdles and increasing concern about adverse side effects. It has also become clear that the traditional business model of pharmaceutical companies is no longer sustainable. Pharmaceutical companies are now seeking to find better ways to reduce operational costs and increase output of new drugs through innovation within research and development.

Drug research and development is a dynamic process, requiring integration of activities across a number of preclinical scientific disciplines for successful progression of therapeutic candidates. The presentation will review the critical challenges in pharmaceutical R&D and highlight how innovative approaches can help to overcome these hurdles. Dr. Yan will also share some cases to illustrate how Covance has helped its partners reach their unique milestones by applying a seamless and strategic approach.

This webinar is part of a series presented by Covance titled “Insights on Improving Global Drug Development from Bench to Commercialization.” For more information about the series or to register for this webinar visit: Transitioning from Bench into Clinical Phase.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Contact:
Michelle Tran
Tel: +1 (416) 977-6555 ext 352
Email: mtran(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2014/08/prweb12116402.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Oklahoma State Medicaid Adopts Drug Price Benchmark, PAC
2. FarHawk Marketing Services Represents IonBench™ and MS Noise™ at the Greater Boston Mass Spectrometry Discussion Group Corporate Night October 3rd
3. Xinmeiya Technology Releases Their 5C7-195 Benchtop Thermoelectric Controller
4. AEgis Technologies Announces Official Launch of ADME WorkBench Software for Pharmacokinetics Prediction
5. iLab Solutions Announces the Results of the 2013 Core Facility Benchmarking Study
6. BioInformatics, LLC Deploys RateMyProduct™ to Rate Benchtop Real-time PCR Machines
7. Global Catalysts Industry 2013-2018: Trend, Profit, and Forecast Analysis - Benchmark the Worlds Top 5 Drug Companies
8. InspireMD To Participate In Benchmark Investor Conference On May 30th
9. HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013
10. Benchmark Research Honored With Industry Accolades
11. PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , Jan. 17, 2017  Only nine percent of ... over profits, while only 16 percent believe health insurance ... today. Meanwhile, 36 percent of U.S. adults believe health ... over profits, compared to hospitals (23%). "We ... said Wendy Salomon , vice president of reputation ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... meeting of the North American Spine Society (NASS)1 demonstrate high fusion rates ... of cases, when PEEK-OPTIMA™ HA Enhanced is used for interbody-fusion devices. The ...
(Date:1/17/2017)... ... January 17, 2017 , ... One Million ... Consortium™ (SafeTEC™), $3 million in investment towards 15+ TEC Validation Projects™. As a ... and their applicability in drug safety assessment, for the industry as a whole. ...
(Date:1/17/2017)... ... January 17, 2017 , ... Diagenode, a leading ... a collaboration with the Heidelberg University Hospital and the German Cancer Research Center ... the company’s successful launch of its CATS (Capture and Amplification by Tailing ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec 15, 2016 ... Research and Markets has announced the ... their offering. The report forecasts the global military biometrics ... The report has been prepared based on an in-depth ... landscape and its growth prospects over the coming years. The report also ...
(Date:12/8/2016)... Dec. 8, 2016 Market Research Future published a half ... global Mobile Biometric Security and Service Market is expected to grow ... Market Highlights: ... , Mobile Biometric Security and ... the increasing need of authentication and security from unwanted cyber threats. ...
(Date:12/7/2016)...   Veridium , a leader in biometrics-based ... CEO James Stickland . Stickland, a seasoned ... has served in senior executive roles for HSBC, ... expanding a pipeline of venture capital and accelerating ... served as managing director of U.K.-based fintech firm ...
Breaking Biology News(10 mins):